US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 9.410
  • +0.050+0.53%
Close Jan 17 16:00 ET
  • 9.410
  • 0.0000.00%
Post 16:03 ET
2.81BMarket Cap-27.68P/E (TTM)

Amicus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amicus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 140.726M--
--2024/Q4-- / 149.641M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 140.726M--
--2024/Q4-- / 149.641M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--

Unlock Free Earnings Estimates

Amicus Therapeutics Earnings Reports

  • Amicus Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:11 ET

  • Amicus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:48 ET

  • Amicus Therapeutics | 8-K: Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates

    Aug 8, 2024 07:04 ET

  • Amicus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9, 2024 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 17, 2025

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data